Searched for
EPIRUS
The U.S. Marines bought an $11 million microwave weapon to counter fiber-optic drones; new HAVOC system follows a $5.5 million predecessor as the Corps tackles radio-silent threats- Quote of the day by Alexander the Great: "Through every generation of the human race there has been a constant war, a war with..." — Inspiring life lessons on freedom, discipline, resilience, perseverance, and why conquering fear precedes every great victory by the history's greatest military commanders
- Quote of the Day by Alexander the Great: 'I do not steal victory…'—Inspiring quotes by the renowned military genius
- Elon Musk's SpaceX is frontrunner to build Donald Trump's "Golden Dome" missile shieldSpaceX, Palantir, and Anduril are leading contenders for a key role in President Trump's "Golden Dome" missile defense shield. Their propos...17 Apr, 2025, 05.32 PM IST
- End of kamikaze drones? Defense startup unveils Star Trek-style ‘laser’ shield that vaporizes killer drones in secondsEpirus has unveiled the innovative Leonidas laser shield, designed to disable swarms of drones using high-powered microwaves. Recently secu...27 Mar, 2025, 11.21 AM IST
- New spin on a revolving door: Pentagon officials-turned-venture capitalistsRetiring generals and departing top Pentagon officials once migrated regularly to the big established weapons makers such as Lockheed Marti...31 Dec, 2023, 01.25 PM IST
- Reliance Life gains global rights for copies of InfliximabFor Infliximab, Reliance Life Sciences had completed process development, manufacturing, clinical trials in India and obtained marketing ap...26 Jul, 2016, 04.30 AM IST
- Reliance Life Sciences ends deal with Epirus for Remicade copiesJanssen’s Remicade is the third biggest pharmaceutical brand globally with sales exceeding $8 billion last year.15 Oct, 2015, 04.26 AM IST
- Sun Pharma’s US arm Taro buys Zalicus Pharmaceuticals of CanadaTaro has acquired Canada’s Zalicus, a company engaged in the development of a pain management drug candidate coded Z944.14 Oct, 2015, 04.49 PM IST
- How Dr Reddy’s is rebooting its biosimilars playDr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.29 Sep, 2015, 02.51 AM IST
- Ranbaxy launches arthritis drug Infimab in IndiaInfimab has been introduced in the Indian market through a licensing partnership with Epirus Biopharmaceuticals, Ranbaxy said in a statemen...01 Dec, 2014, 05.17 PM IST
- Ranbaxy narrows Q4 loss on US acne drug salesPharma major Ranbaxy Laboratories today reported a drastic drop in net loss at Rs 158.48 crore during the fourth quarter ended December 31,...05 Feb, 2014, 12.56 PM IST
- Ranbaxy enters into licensing pact with EPIRUS SwitzerlandRanbaxy Laboratories have entered into a licensing pact with EPIRUS Switzerland GmbH for treating rheumatoid arthiritis.09 Jan, 2014, 02.28 PM IST
Load More
